Stocks to Watch Today, 19th May 2025: Divi's Laboratories, Logistics company Delhivery, and more
Indian share markets are expected to start the trading day on a subdued note this Monday, May 19, 2025. Market players seem to be waiting for new triggers before taking meaningful directional action. Until 7:50 AM, the GIFT Nifty was at 25,063, lower by 16 points, which reflects a guarded opening.
Global Indicators Weigh
Global sentiment seems weak. Asian markets were generally on the backfoot. Japan's Nikkei fell 0.54%, South Korea's Kospi by 1%, Hong Kong's Hang Seng by 0.45%, and Australia's ASX200 by 0.02%. Key economic indicators are also being watched by investors, such as China's April readings on housing prices and industrial output, due to be published today. The Reserve Bank of Australia is also starting its two-day policy meeting. To the nervous sentiment, Moody's Ratings downgraded the US sovereign credit rating from 'Aaa' to 'Aa1' on Friday. This move affected US futures, with those related to the Dow Jones Industrial Average, S&P 500, and Nasdaq 100 dropping approximately 0.7% to 0.8% on Monday morning.
Stock to focus
Divi's Laboratories posted a 23% quarter-on-quarter growth in net profit at ₹662 crore for Q4FY25. Revenue grew 12.2% to ₹2,585 crore with EBITDA improving 21.2%. Final dividend of ₹30 per share has been recommended by the board.
Delhivery became profitable in Q4 FY25 with a net profit of ₹72.6 crore versus last year's loss during the same quarter. Topline rose 5.6% to ₹2,191.5 crore, and EBITDA more than doubled to ₹119 crore.
Shipping Corporation of India posted its net profit decreasing 39.73% year on year to ₹185 crore during Q4 FY25, with top line declining around 6%.
Texmaco Rail & Engineering posted a 17.6% increase in revenue and 16.7% increase in EBITDA year-on-year but a 12.2% drop in net profit.
Arvind Fashions posted a net loss of ₹93.15 crore in the fourth quarter, a reversal of the previous year's profit, even as revenue rose 8.8% and EBITDA increased 18%.
KEC International, a Company of RPG Group, has won multiple new orders worth ₹1,133 crore for Transmission & Distribution projects, which include a major order from Power Grid Corporation of India.
Bharat Electronics (BEL reported more orders worth ₹572 crore won after April 7, 2025, for different systems such as IDDIS, SDR, and AI-based solutions.
Vodafone Idea is making headlines after taking the case to the Supreme Court against the government's rejection of its request for a waiver of more than $5 billion in interest and fines on statutory dues.
Premier Energies has entered into an agreement to establish a Joint Venture, Premier Green Aluminium Private Limited, with Nuevosol Energy Private Limited to produce aluminium frames for solar panels. Premier Energies will own an 80% stake.
NBCC received sales of ₹1,468 crore from the e-auction of 446 residential apartments at Aspire Silicon City in Noida.
Ireda has initiated an Insolvency and Bankruptcy Code application against Gensol EV Lease Limited, a subsidiary of Gensol Engineering, as a result of a default of ₹218.95 crore.
Paradeep Phosphates is anticipating a positive financial effect following the Delhi High Court's order that compelled the Central government to disburse a nutrient-based subsidy of ₹53.50 crore within six weeks.
Bajaj Auto International Holdings BV, a unit of Bajaj Auto, entered into unsecured, one-year term loan deals worth 566 million euros with JP Morgan, DBS Bank, and Citigroup Global Markets Asia.
Crosslay Remedies, a subsidiary of Max Healthcare Institute, completed the purchase of a 4,000 square meter land and building near its Vaishali hospital for ₹120 crore to facilitate the addition of around 140 beds.
JSW Steel's Board meeting will take place on May 23 to discuss raising long-term funds and a dividend distribution proposal.
Sun Pharma said that the US FDA has approved its next-generation BLU-U blue light photodynamic therapy to treat actinic keratosis.
Also Read : Sensex & Nifty Live Updates Today
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here